Nicolas Joubert

1.5k total citations · 1 hit paper
34 papers, 1.2k citations indexed

About

Nicolas Joubert is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Molecular Biology. According to data from OpenAlex, Nicolas Joubert has authored 34 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Radiology, Nuclear Medicine and Imaging, 17 papers in Oncology and 14 papers in Molecular Biology. Recurrent topics in Nicolas Joubert's work include Monoclonal and Polyclonal Antibodies Research (18 papers), HER2/EGFR in Cancer Research (16 papers) and Click Chemistry and Applications (6 papers). Nicolas Joubert is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (18 papers), HER2/EGFR in Cancer Research (16 papers) and Click Chemistry and Applications (6 papers). Nicolas Joubert collaborates with scholars based in France, United States and Czechia. Nicolas Joubert's co-authors include Mathieu Pucheault, Caroline Denevault‐Sabourin, Alain Beck, Charles Dumontet, Marie‐Claude Viaud‐Massuard, Michal Hocek, Luigi A. Agrofoglio, Francesca Bryden, Radek Pohl and Blanka Klepetářová and has published in prestigious journals such as Biochemistry, Journal of Controlled Release and Journal of Medicinal Chemistry.

In The Last Decade

Nicolas Joubert

33 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antibody–Drug Conjugates: The Last Decade

2020 268 citations Nicolas Joubert, Alain Beck et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nicolas Joubert France	16	633	453	422	396	77	34	1.2k
François D’Hooge United Kingdom	16	389 0.6×	286 0.6×	307 0.7×	245 0.6×	75 1.0×	25	940
Kaycie M. Deyle Switzerland	14	1.1k 1.7×	418 0.9×	170 0.4×	287 0.7×	26 0.3×	18	1.4k
Julia Morales‐Sanfrutos Spain	22	1.0k 1.6×	679 1.5×	156 0.4×	225 0.6×	36 0.5×	33	1.5k
Victor Gonçalves France	20	488 0.8×	243 0.5×	243 0.6×	395 1.0×	18 0.2×	42	1.0k
Matthew B. Soellner United States	20	1.6k 2.5×	984 2.2×	276 0.7×	334 0.8×	45 0.6×	48	2.0k
Ziqing Qian United States	24	1.7k 2.7×	552 1.2×	229 0.5×	235 0.6×	30 0.4×	37	2.1k
Burkhardt Laufer Germany	15	743 1.2×	245 0.5×	212 0.5×	232 0.6×	16 0.2×	23	1.1k
Arwin J. Brouwer Netherlands	24	980 1.5×	1.0k 2.3×	173 0.4×	165 0.4×	27 0.4×	46	1.6k
Franciscus M. H. de Groot Netherlands	12	519 0.8×	305 0.7×	312 0.7×	197 0.5×	21 0.3×	15	954
Emily C. Dykhuizen United States	22	1.4k 2.1×	216 0.5×	210 0.5×	156 0.4×	59 0.8×	48	1.7k

Countries citing papers authored by Nicolas Joubert

Since Specialization

Citations

This map shows the geographic impact of Nicolas Joubert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Joubert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Joubert more than expected).

Fields of papers citing papers by Nicolas Joubert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolas Joubert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Joubert. The network helps show where Nicolas Joubert may publish in the future.

Co-authorship network of co-authors of Nicolas Joubert

This figure shows the co-authorship network connecting the top 25 collaborators of Nicolas Joubert. A scholar is included among the top collaborators of Nicolas Joubert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicolas Joubert. Nicolas Joubert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jallas, Anne-Catherine, Ioana Molnar, Cyril Colas, et al.. (2025). Development of Optimized Exatecan-Based Immunoconjugates with Potent Antitumor Efficacy in HER2-Positive Breast Cancer. Journal of Medicinal Chemistry. 68(18). 19122–19142.

Allard-Vannier, Émilie, Aurélie Maisonial‐Besset, Jean‐Michel Chezal, et al.. (2024). Branched pegylated linker-auristatin to control hydrophobicity for the production of homogeneous minibody-drug conjugate against HER2-positive breast cancer. Journal of Controlled Release. 366. 567–584. 7 indexed citations

Garambois, Véronique, Augusto Faria Andrade, Marta Jarlier, et al.. (2023). Improving the response to oxaliplatin by targeting chemotherapy-induced CLDN1 in resistant metastatic colorectal cancer cells. Cell & Bioscience. 13(1). 72–72. 12 indexed citations

Colas, Cyril, et al.. (2022). Intra-Domain Cysteines (IDC), a New Strategy for the Development of Original Antibody Fragment–Drug Conjugates (FDCs). Pharmaceutics. 14(8). 1524–1524. 7 indexed citations

Viaud‐Massuard, Marie‐Claude, et al.. (2021). Dual intra- and extracellular release of monomethyl auristatin E from a neutrophil elastase-sensitive antibody-drug conjugate. European Journal of Medicinal Chemistry. 229. 114063–114063. 9 indexed citations

Denevault‐Sabourin, Caroline, Nicolas Joubert, Jean‐Pierre Pouget, et al.. (2021). Therapeutic antibodies – natural and pathological barriers and strategies to overcome them. Pharmacology & Therapeutics. 233. 108022–108022. 22 indexed citations

Beck, Alain, Charles Dumontet, & Nicolas Joubert. (2019). Les immuno-conjugués en oncologie. médecine/sciences. 35(12). 1034–1042. 5 indexed citations

Beck, Alain, Charles Dumontet, & Nicolas Joubert. (2019). Les immunoconjugués en oncologie. médecine/sciences. 35(12). 1043–1053. 5 indexed citations

Hervé-Aubert, Katel, Émilie Allard-Vannier, Nicolas Joubert, et al.. (2018). Impact of Site-Specific Conjugation of ScFv to Multifunctional Nanomedicines Using Second Generation Maleimide. Bioconjugate Chemistry. 29(5). 1553–1559. 10 indexed citations

10.

Aubrey, Nicolas, Émilie Allard-Vannier, Francesca Bryden, et al.. (2018). Site-Specific Conjugation of Auristatins onto Engineered scFv Using Second Generation Maleimide to Target HER2-positive Breast Cancer in Vitro. Bioconjugate Chemistry. 29(11). 3516–3521. 24 indexed citations

11.

Bryden, Francesca, Cyril Colas, Émilie Allard-Vannier, et al.. (2018). Impact of cathepsin B-sensitive triggers and hydrophilic linkers onin vitroefficacy of novel site-specific antibody–drug conjugates. Organic & Biomolecular Chemistry. 16(11). 1882–1889. 36 indexed citations

12.

Joubert, Nicolas, Caroline Denevault‐Sabourin, Francesca Bryden, & Marie‐Claude Viaud‐Massuard. (2017). Towards antibody-drug conjugates and prodrug strategies with extracellular stimuli-responsive drug delivery in the tumor microenvironment for cancer therapy. European Journal of Medicinal Chemistry. 142. 393–415. 65 indexed citations

13.

Brachet, Guillaume, Renaud Respaud, Christophe Arnoult, et al.. (2016). Increment in Drug Loading on an Antibody–Drug Conjugate Increases Its Binding to the Human Neonatal Fc Receptor in Vitro. Molecular Pharmaceutics. 13(4). 1405–1412. 22 indexed citations

14.

Joubert, Nicolas, et al.. (2010). Protein Chemical Modification on Endogenous Amino Acids. Chemistry & Biology. 17(3). 213–227. 345 indexed citations

15.

Joubert, Nicolas, et al.. (2010). Mild, base-free copper-catalyzed N-arylations of heterocycles using potassium aryltrifluoroborates in water under air. Tetrahedron Letters. 51(22). 2994–2997. 19 indexed citations

16.

Hari, Yoshiyuki, Gil Tae Hwang, Aaron M. Leconte, et al.. (2008). Optimization of the Pyridyl Nucleobase Scaffold for Polymerase Recognition and Unnatural Base Pair Replication. ChemBioChem. 9(17). 2796–2799. 24 indexed citations

17.

Joubert, Nicolas, et al.. (2008). Synthesis and anti-HIV activity of 5-haloethynyl and 5-(1,2-dihalo)vinyl analogues of AZT and FLT. Tetrahedron. 64(19). 4444–4452. 9 indexed citations

18.

Broggi, Julie, Nicolas Joubert, Silvia Díez‐González, et al.. (2008). Synthesis of (±)-1,2,3-triazolo-3′-deoxy-4′-hydroxymethyl carbanucleosides via ‘click’ cycloaddition. Tetrahedron. 65(6). 1162–1170. 22 indexed citations

19.

Joubert, Nicolas, Radek Pohl, Blanka Klepetářová, & Michal Hocek. (2007). ChemInform Abstract: Modular and Practical Synthesis of 6‐Substituted Pyridin‐3‐yl C‐Nucleosides.. ChemInform. 39(2). 7 indexed citations

20.

Escuret, Vanessa, Vincent Aucagne, Nicolas Joubert, et al.. (2005). Synthesis of 5-haloethynyl- and 5-(1,2-dihalo)vinyluracil nucleosides: Antiviral activity and cellular toxicity. Bioorganic & Medicinal Chemistry. 13(21). 6015–6024. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact